Shire PLC (NASDAQ:SHPG)

216.73
Data as of Dec 19
 -4.15 / -1.88%
Today’s Change
136.68
Today|||52-Week Range
264.98
+53.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$42.6B

Company Description

Shire Plc is a biopharmaceutical company that focuses on meeting the needs of physicians. It focuses its business on attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases, as well as opportunities in other therapeutic areas. It operates under three segments which include Specialty Pharma, Human Genetic Therapies and Regenerative Medicine. The Specialty Pharmaceuticals segment focuses on small-molecule medications, including Vyvanse for the treatment of attention deficit hyperactivity disorder in children aged 6 to 17, FOSRENOL for the treatment of chronic kidney disease in pre-dialysis patients, XAGRID for the treatment of essential thrombocythaemia, JUVISTA for the improvement of scar appearance, LIALDA/MEZAVANT for the treatment of diverticulitis and RESOLOR for the treatment of chronic constipation in males. The Human Genetic Therapies segment offers products, including FIRAZYR for the treatment of acute hereditary angioedema, REPLAGAL for fabry disease and HGT-2310 for the treatment of Hunter syndrome with central nervous system symptoms, idursulfase-intrathecal delivery. The Regenerative Medicine segment focuses on Dermagraft, a bioengineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 1986 and is headquartered in Dublin, Ireland.

Contact Information

Shire Plc
5 Riverwalk
Dublin -- 24
P:(531) 429-7700
Investor Relations:
(531) 482-0999

Employees

Shareholders

Mutual fund holders6.48%
Other institutional20.24%
Individual stakeholders--

Top Executives

Flemming ØrnskovChief Executive Officer & Director
James BowlingChief Financial Officer, Senior VP & Controller
Philip J. VickersHead-Research & Development
Mario SaltarelliSenior VP-Clinical Development & Medical Affairs
Jeff PoultonSenior Vice President & Head-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.